Abhinav BeeravallyNagulapally

发表

A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma

D. Eslin, P. Zage, T. Higgins, 2023, International journal of cancer.